These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9811680

  • 1. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells.
    Rothmann T, Hengstermann A, Whitaker NJ, Scheffner M, zur Hausen H.
    J Virol; 1998 Dec; 72(12):9470-8. PubMed ID: 9811680
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Anti-tumor effect of E1B55kDa-deleted adenovirus on human hepatocellular carcinoma cell lines].
    Zhao J, Lü Y, Guo Y.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):366-8. PubMed ID: 11810762
    [Abstract] [Full Text] [Related]

  • 5. Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.
    Hann B, Balmain A.
    J Virol; 2003 Nov; 77(21):11588-95. PubMed ID: 14557644
    [Abstract] [Full Text] [Related]

  • 6. Genetically modified adenoviruses against gliomas: from bench to bedside.
    Gomez-Manzano C, Yung WK, Alemany R, Fueyo J.
    Neurology; 2004 Aug 10; 63(3):418-26. PubMed ID: 15304571
    [Abstract] [Full Text] [Related]

  • 7. Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).
    Ries SJ, Brandts CH, Chung AS, Biederer CH, Hann BC, Lipner EM, McCormick F, Korn WM.
    Nat Med; 2000 Oct 10; 6(10):1128-33. PubMed ID: 11017144
    [Abstract] [Full Text] [Related]

  • 8. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.
    O'Shea CC, Johnson L, Bagus B, Choi S, Nicholas C, Shen A, Boyle L, Pandey K, Soria C, Kunich J, Shen Y, Habets G, Ginzinger D, McCormick F.
    Cancer Cell; 2004 Dec 10; 6(6):611-23. PubMed ID: 15607965
    [Abstract] [Full Text] [Related]

  • 9. Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.
    McCormick F.
    Semin Cancer Biol; 2000 Dec 10; 10(6):453-9. PubMed ID: 11170867
    [Abstract] [Full Text] [Related]

  • 10. Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer.
    Thorne SH, Brooks G, Lee YL, Au T, Eng LF, Reid T.
    J Virol; 2005 Jan 10; 79(1):581-91. PubMed ID: 15596850
    [Abstract] [Full Text] [Related]

  • 11. ONYX-015 selectivity and the p14ARF pathway.
    McCormick F.
    Oncogene; 2000 Dec 27; 19(56):6670-2. PubMed ID: 11426653
    [Abstract] [Full Text] [Related]

  • 12. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.
    Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, McCormick F.
    Science; 1996 Oct 18; 274(5286):373-6. PubMed ID: 8832876
    [Abstract] [Full Text] [Related]

  • 13. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.
    Shinoura N, Yoshida Y, Tsunoda R, Ohashi M, Zhang W, Asai A, Kirino T, Hamada H.
    Cancer Res; 1999 Jul 15; 59(14):3411-6. PubMed ID: 10416603
    [Abstract] [Full Text] [Related]

  • 14. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.
    Shen Y, Kitzes G, Nye JA, Fattaey A, Hermiston T.
    J Virol; 2001 May 15; 75(9):4297-307. PubMed ID: 11287579
    [Abstract] [Full Text] [Related]

  • 15. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
    Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Terrier-Lacombe MJ, Bressac De-Paillerets B, Barrois M, Feunteun J, Kirn DH, Vassal G.
    Cancer Res; 2002 Feb 01; 62(3):764-72. PubMed ID: 11830531
    [Abstract] [Full Text] [Related]

  • 16. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
    Vollmer CM, Ribas A, Butterfield LH, Dissette VB, Andrews KJ, Eilber FC, Montejo LD, Chen AY, Hu B, Glaspy JA, McBride WH, Economou JS.
    Cancer Res; 1999 Sep 01; 59(17):4369-74. PubMed ID: 10485485
    [Abstract] [Full Text] [Related]

  • 17. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.
    Ganly I, Kirn D, Eckhardt G, Rodriguez GI, Soutar DS, Otto R, Robertson AG, Park O, Gulley ML, Heise C, Von Hoff DD, Kaye SB.
    Clin Cancer Res; 2000 Mar 01; 6(3):798-806. PubMed ID: 10741699
    [Abstract] [Full Text] [Related]

  • 18. Oncolysis of human gastric cancers by an E1B 55 kDa-deleted YKL-1 adenovirus.
    Lee B, Choi J, Kim J, Kim JH, Joo CH, Cho YK, Kim YK, Lee H.
    Cancer Lett; 2002 Nov 28; 185(2):225-33. PubMed ID: 12169397
    [Abstract] [Full Text] [Related]

  • 19. p53-dependent cell death/apoptosis is required for a productive adenovirus infection.
    Hall AR, Dix BR, O'Carroll SJ, Braithwaite AW.
    Nat Med; 1998 Sep 28; 4(9):1068-72. PubMed ID: 9734403
    [Abstract] [Full Text] [Related]

  • 20. Replicating adenoviruses in cancer therapy.
    Dobbelstein M.
    Curr Top Microbiol Immunol; 2004 Sep 28; 273():291-334. PubMed ID: 14674605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.